Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations
- PMID: 29630631
- PMCID: PMC5891012
- DOI: 10.1371/journal.pone.0195513
Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations
Abstract
Cell signaling is the process by which extracellular information is transmitted into the cell to perform useful biological functions. The ERK (extracellular-signal-regulated kinase) signaling controls several cellular processes such as cell growth, proliferation, differentiation and apoptosis. The ERK signaling pathway considered in this work starts with an extracellular stimulus and ends with activated (double phosphorylated) ERK which gets translocated into the nucleus. We model and analyze this complex pathway by decomposing it into three functional subsystems. The first subsystem spans the initial part of the pathway from the extracellular growth factor to the formation of the SOS complex, ShC-Grb2-SOS. The second subsystem includes the activation of Ras which is mediated by the SOS complex. This is followed by the MAPK subsystem (or the Raf-MEK-ERK pathway) which produces the double phosphorylated ERK upon being activated by Ras. Although separate models exist in the literature at the subsystems level, a comprehensive model for the complete system including the important regulatory feedback loops is missing. Our dynamic model combines the existing subsystem models and studies their steady-state and dynamic interactions under feedback. We establish conditions under which bistability and oscillations exist for this important pathway. In particular, we show how the negative and positive feedback loops affect the dynamic characteristics that determine the cellular outcome.
Conflict of interest statement
Figures













References
-
- Santos SDM, Verveer PJ, Bastiaens PIH. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol. 2007;9(3). - PubMed
-
- Gille H, Downward J. Multiple Ras effector pathways contribute to G1 cell cycle progression. J Biol Chem. 1999;274(31):22033–40. - PubMed
-
- Lu Z, Xu S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 2006. 58(11):621–31. doi: 10.1080/15216540600957438 - DOI - PubMed
-
- Santarpia LL, Lippman S, El-Naggar A. Targeting the Mitogen-Activated Protein Kinase RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103–19. doi: 10.1517/14728222.2011.645805 - DOI - PMC - PubMed
-
- Fey D, Matallanas D, Rauch J, Rukhlenko OS, Kholodenko BN. The complexities and versatility of the RAS-to-ERK signaling system in normal and cancer cells. Semin Cell Dev Biol. 2016;58:96–107. Available from: doi: 10.1016/j.semcdb.2016.06.011 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous